135 related articles for article (PubMed ID: 22075233)
1. New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.
Heng S; Tieu W; Hautmann S; Kuan K; Pedersen DS; Pietsch M; Gütschow M; Abell AD
Bioorg Med Chem; 2011 Dec; 19(24):7453-63. PubMed ID: 22075233
[TBL] [Abstract][Full Text] [Related]
2. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase.
Li B; Zhou B; Lu H; Ma L; Peng AY
Eur J Med Chem; 2010 May; 45(5):1955-63. PubMed ID: 20149492
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase.
Wei Y; Peng AY; Wang B; Ma L; Peng G; Du Y; Tang J
Eur J Med Chem; 2014 Mar; 74():751-8. PubMed ID: 23601990
[TBL] [Abstract][Full Text] [Related]
4. 5-benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials.
Zvarec O; Polyak SW; Tieu W; Kuan K; Dai H; Pedersen DS; Morona R; Zhang L; Booker GW; Abell AD
Bioorg Med Chem Lett; 2012 Apr; 22(8):2720-2. PubMed ID: 22444680
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
Pietsch M; Gütschow M
J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
[TBL] [Abstract][Full Text] [Related]
6. A new synthesis of fully phosphorylated flavones as potent pancreatic cholesterol esterase inhibitors.
Peng G; Du Y; Wei Y; Tang J; Peng AY; Rao L
Org Biomol Chem; 2011 Apr; 9(7):2530-4. PubMed ID: 21340062
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors.
Shafii N; Khoobi M; Amini M; Sakhteman A; Nadri H; Moradi A; Emami S; Saeedian Moghadam E; Foroumadi A; Shafiee A
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):389-95. PubMed ID: 26095345
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.
Liu J; Wu F; Chen L; Hu J; Zhao L; Chen C; Peng L
Bioorg Med Chem Lett; 2011 Apr; 21(8):2376-9. PubMed ID: 21411319
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
John S; Thangapandian S; Sakkiah S; Lee KW
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase.
Zidar N; Tomasić T; Sink R; Rupnik V; Kovac A; Turk S; Patin D; Blanot D; Contreras Martel C; Dessen A; Müller Premru M; Zega A; Gobec S; Peterlin Masic L; Kikelj D
J Med Chem; 2010 Sep; 53(18):6584-94. PubMed ID: 20804196
[TBL] [Abstract][Full Text] [Related]
11. Identification and synthesis of selective cholesterol esterase inhibitor using dynamic combinatorial chemistry.
Zhao S; Wu Y; Hu L
Bioorg Chem; 2022 Feb; 119():105520. PubMed ID: 34864280
[TBL] [Abstract][Full Text] [Related]
12. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
13. Isocoumarin-based inhibitors of pancreatic cholesterol esterase.
Heynekamp JJ; Hunsaker LA; Vander Jagt TA; Royer RE; Deck LM; Vander Jagt DL
Bioorg Med Chem; 2008 May; 16(9):5285-94. PubMed ID: 18353652
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors.
Ahn JH; Kim SJ; Park WS; Cho SY; Ha JD; Kim SS; Kang SK; Jeong DG; Jung SK; Lee SH; Kim HM; Park SK; Lee KH; Lee CW; Ryu SE; Choi JK
Bioorg Med Chem Lett; 2006 Jun; 16(11):2996-9. PubMed ID: 16530413
[TBL] [Abstract][Full Text] [Related]
15. Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.
Singh H; Singh JV; Gupta MK; Singh P; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Feb; 27(4):850-854. PubMed ID: 28117203
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
[TBL] [Abstract][Full Text] [Related]
17. Potential human cholesterol esterase inhibitor design: benefits from the molecular dynamics simulations and pharmacophore modeling studies.
John S; Thangapandian S; Lee KW
J Biomol Struct Dyn; 2012; 29(5):921-36. PubMed ID: 22292952
[TBL] [Abstract][Full Text] [Related]
18. Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase.
Doorn JA; Talley TT; Thompson CM; Richardson RJ
Chem Res Toxicol; 2001 Jul; 14(7):807-13. PubMed ID: 11453726
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase.
Muscia GC; Hautmann S; Buldain GY; Asís SE; Gütschow M
Bioorg Med Chem Lett; 2014 Mar; 24(6):1545-9. PubMed ID: 24556381
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors.
Chauhan D; George G; Sridhar SNC; Bhatia R; Paul AT; Monga V
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900029. PubMed ID: 31407389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
